Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 186

The market loves growth stocks – until it doesn’t

In light of the recent misfortunes suffered by high-profile ASX growth stocks (Bellamy’s, Estia Health, and iSentia Group to name a few), it’s worthwhile seeing if there are any obvious lessons investors can take into 2017.

Growth stocks by their nature tell a story that provides some justification of their future earnings potential. These stocks can dazzle as their futures unfold, but it’s important to remember the other side of the trade when things don’t go as planned.

High profile growth stocks volatile

Firstly, from a risk perspective, investors benefit from knowing how a growth stock will compare with the wider market. Beta is the measure of the volatility of a security versus the market. It can provide an indication of how volatile or ‘wild’ the ride might be, from both positive and negative sides. For example, if growth Company A has a market beta of 1.5 it is likely to be 50% more volatile than the market. That is, if the market goes up 1% then Company A should rise 1.5% and if the market falls by 1% Company A should fall by 1.5%.

Secondly, the cliché ‘up the stairs down the elevator’ is particularly relevant when looking at growth stocks. Put simply, a company is more likely to go from overvalued to undervalued far more quickly than from undervalued to overvalued. Growth stocks are either undervalued or overvalued but rarely fairly valued. We know the higher the price the higher the risk, yet our FOMO (fear of missing out) may cause us to jump into a growth stock, chasing and in fact promoting the ‘paper profits’ seen by the earlier investors.

On the flip side, our apprehension may cause us to sell out at a large and sudden discount even though the risks of the business are provided at a large discount.

Market has a short memory

If you ask the question (assuming business fundamentals remain), that if I was happy to buy stock at a 30% discounted price on the way up, shouldn’t I be considering buying it now?

The market tends to have a short memory and is always willing to be swept away by the next big growth stock. If we take a look back to calendar year 2015, the top 10 performers in the All Ordinaries Index produced an average return of approximately 400% (if you exclude resource companies, the top 10 performers returned an average of approximately 275%). Leading the charge were the market darlings, Bellamy’s and Blackmores, which had P/Es of 140 and 80 respectively during that time. The market is forward looking to a current P/E on a growth stock so it will invariably look high, but these figures also provide a sense of relativity to the general market P/E range of 15-17.

If we look at those same performing stocks in calendar year 2016 (so far), the return of the non-resource top 10 market darlings from 2015 is -18%, excluding one which has gone into liquidation. Of those which have produced negative returns, the average is -35%. A company reinvesting for growth often means you don’t have a dividend yield to soften the loss, and an investor that arrives late to the party can end up with negative returns quickly.

Here are four lessons to keep in mind before investing in growth stocks:

  • have a price level of where you think the stock is either undervalued or overvalued and write it down so you don’t forget
  • don’t ignore a company’s beta - the higher the beta, the higher the risk of a larger pullback
  • chasing someone else’s paper profit is not a sound investment decision
  • if you’re caught up in a large correction, take your time to weigh the options in the context of undervalued vs overvalued. Has the bubble burst or is this an opportunity to buy at a price you could only have dreamed of a few days ago?

 

Robert Miller is a Portfolio Manager at NAOS Asset Management. NAOS runs two LICs, ASX:NCC and ASX:NAC. This article is general information and does not consider the circumstances or investment needs of any individual.

 

RELATED ARTICLES

Searching for value in tech stocks

Six ratios show the market is off the charts

4 lessons from Marks on protecting capital

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.